Cardiac MRI T1, T2, and T2* parametric mapping techniques allow both visual and quantitative
myocardial assessment, detecting focal and global tissue changes.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Advances in Clinical RadiologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Normal human right and left ventricular mass, systolic function, and gender differences by cine magnetic resonance imaging.J Cardiovasc Magn Reson. 1999; 1: 7-21
- Accuracy, precision, and reproducibility of four T1 mapping sequences: a head-to-head comparison of MOLLI, ShMOLLI, SASHA, and SAPPHIRE.Radiology. 2014; 272: 683-689
- T1mapping in cardiac MRI.Heart Fail Rev. 2017; 22: 415-430
- T1 mapping basic techniques and clinical applications.JACC Cardiovasc Imaging. 2016; 9: 67-81
- Variability of cardiovascular magnetic resonance (CMR) T1 mapping parameters in healthy volunteers during long-term follow-up.Open Heart. 2018; 5: e000717
- Measurement of the distribution volume of gadopentetate dimeglumine at echo-planar MR imaging to quantify myocardial infarction: comparison with 99m Tc-DTPA autoradiography in rats.Radiology. 1999; 211: 698-708
- Noninvasive hematocrit assessment for cardiovascular magnetic resonance extracellular volume quantification using a point-of-care device and synthetic derivation.J Cardiovasc Magn Reson. 2018; 20: 1-9
- Automatic measurement of the myocardial interstitium synthetic extracellular volume quantification without hematocrit sampling.JACC Cardiovasc Imaging. 2016; 9: 54-63
- Importance of standardizing timing of hematocrit measurement when using cardiovascular magnetic resonance to calculate myocardial extracellular volume (ECV) based on pre- and post-contrast T1 mapping.J Cardiovasc Magn Reson. 2018; 20: 46
- Human myocardium: single-breath-hold MR T1 mapping with high spatial resolution—reproducibility study.Radiology. 2006; 238: 1004-1012
- Age and sex corrected normal reference values of T1, T2 T2∗and ECV in healthy subjects at 3T CMR.J Cardiovasc Magn Reson. 2017; 19: 72
- T1 mapping of the myocardium: intra-individual assessment of post-contrast T1 time evolution and extracellular volume fraction at 3T for Gd-DTPA and Gd-BOPTA.J Cardiovasc Magn Reson. 2012; 14: 26
- T1, T2 relaxation and magnetization transfer in tissue at 3T.Magn Reson Med. 2005; 54: 507-512
- Comparison of different cardiovascular magnetic resonance sequences for native myocardial T1 mapping at 3T.J Cardiovasc Magn Reson. 2016; 18: 1-12
- Myocardial T1 and T2 mapping at 3 T: reference values, influencing factors and implications.J Cardiovasc Magn Reson. 2013; 15: 53
- Native myocardial longitudinal (T1) relaxation time: regional, age, and sex associations in the healthy adult heart.J Magn Reson Imaging. 2016; 44: 541-548
- Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2 and extracellular volume: a consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging.J Cardiovasc Magn Reson. 2017; 19: 75
- Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement.J Cardiovasc Magn Reson. 2013; 15: 92
- Cardiovascular magnetic resonance measurement of myocardial extracellular volume in health and disease.Heart. 2012; 98: 1436-1441
- T1 and extracellular volume mapping in the heart: estimation of error maps and the influence of noise on precision.J Cardiovasc Magn Reson. 2013; 15: 56
- Variability and homogeneity of cardiovascular magnetic resonance myocardial T2-mapping in volunteers compared to patients with edema.J Cardiovasc Magn Reson. 2013; 15: 27
- T2 measurement of the human myocardium using a T 2-prepared transient-state trueFISP sequence.Magn Reson Med. 2007; 57: 960-966
- T2 quantification for improved detection of myocardial edema.J Cardiovasc Magn Reson. 2009; 11: 56
- A systematic evaluation of three different cardiac T2-mapping sequences at 1.5 and 3T in healthy volunteers.Eur J Radiol. 2015; 84: 2161-2170
- Myocardial T2 mapping reveals age- and sex-related differences in volunteers.J Cardiovasc Magn Reson. 2015; 17: 9
- Corrected equations for susceptibility-induced T2-Shortening.J Magn Reson. 1999; 137: 402-407
- International reproducibility of single breathhold T2* MR for cardiac and liver iron assessment among five thalassemia centers.J Magn Reson Imaging. 2010; 32: 315-319
- Value of black blood T2* cardiovascular magnetic resonance.J Cardiovasc Magn Reson. 2011; 13: 21
- Cardiovascular function and treatment in β-thalassemia major: a consensus statement from the American Heart Association.Circulation. 2013; 128: 281-308
- T1 and T2 mapping in recognition of early cardiac involvement in systemic sarcoidosis.Radiology. 2017; 285: 63-72
- Abnormal T2 mapping cardiovascular magnetic resonance correlates with adverse clinical outcome in patients with suspected acute myocarditis.J Cardiovasc Magn Reson. 2017; 19: 38
- Cardiac MRI evaluation of myocardial disease.Heart. 2016; 102: 1429-1435
- Myocardial fibrosis quantified by extracellular volume is associated with subsequent hospitalization for heart failure, death, or both across the spectrum of ejection fraction and heart failure stage.J Am Heart Assoc. 2015; 4: e002613
- Histologic validation of myocardial fibrosis measured by T1 mapping: a systematic review and meta-analysis.J Cardiovasc Magn Reson. 2016; 18: 92
- Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance.J Am Coll Cardiol. 2009; 54: 220-228
- Assessing myocardial extracellular volume by T1 mapping to distinguish hypertrophic cardiomyopathy from athlete’s heart.J Am Coll Cardiol. 2016; 67: 2189-2190
- A comprehensive evaluation of myocardial fibrosis in hypertrophic cardiomyopathy with cardiac magnetic resonance imaging: linking genotype with fibrotic phenotype.Eur Heart J Cardiovasc Imaging. 2014; 15: 1108-1116
- Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans.Circulation. 2010; 122: 138-144
- Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy.JACC Cardiovasc Imaging. 2013; 6: 475-484
- Myocardial tissue characterization using magnetic resonance noncontrast T1 mapping in hypertrophic and dilated cardiomyopathy.Circ Cardiovasc Imaging. 2012; 5: 726-733
- Contemporary definitions and classification of the cardiomyopathies: An American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention.Circulation. 2006; 113: 1807-1816
- Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy.J Am Coll Cardiol. 2006; 48: 1977-1985
- Extracellular volume fraction in dilated cardiomyopathy patients without obvious late gadolinium enhancement: comparison with healthy control subjects.Int J Cardiovasc Imaging. 2015; 31: 115-122
- T1 mapping in dilated cardiomyopathy with cardiac magnetic resonance: quantification of diffuse myocardial fibrosis and comparison with endomyocardial biopsy.Eur Heart J Cardiovasc Imaging. 2015; 16: 210-216
- Aortic stiffness and interstitial myocardial fibrosis by native t1 are independently associated with left ventricular remodeling in patients with dilated cardiomyopathy.Hypertension. 2014; 64: 762-768
- T1and T2mapping for early diagnosis of dilated non-ischaemic cardiomyopathy in middle-aged patients and differentiation from normal physiological adaptation.Eur Heart J Cardiovasc Imaging. 2016; 17: 797-803
- Cardiovascular magnetic resonance T2 mapping detects myocardial edema in patients with chronic dilated cardiomyopathy.J Cardiovasc Magn Reson. 2012; 14: O29
- Evidence of myocardial edema in patients with nonischemic dilated cardiomyopathy.Clin Cardiol. 2012; 35: 371-376
- Prognostic effect of inappropriately high left ventricular mass in asymptomatic severe aortic stenosis.Heart. 2011; 97: 301-307
- Assessment of diffuse myocardial fibrosis by using MR imaging in asymptomatic patients with aortic stenosis.Radiology. 2015; 274: 359-369
- T1 mapping for myocardial extracellular volume measurement by CMR: bolus only versus primed infusion technique.JACC Cardiovasc Imaging. 2013; 6: 955-962
- Myocardial T1 mapping: application to patients with acute and chronic myocardial infarction.Magn Reson Med. 2007; 58: 34-40
- Diagnostic value of pre-contrast T1 mapping in acute and chronic myocardial infarction.JACC Cardiovasc Imaging. 2013; 6: 739-742
- Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology.Eur Heart J. 2012; 33: 1268-1278
- Direct T2 quantification of myocardial edema in acute ischemic injury.JACC Cardiovasc Imaging. 2011; 4: 269-278
- Myocardial edema as detected by pre-contrast T1 and T2 CMR delineates area at risk associated with acute myocardial infarction.JACC Cardiovasc Imaging. 2012; 5: 596-603
- T1 mapping and T2 mapping at 3T for quantifying the area-at-risk in reperfused STEMI patients.J Cardiovasc Magn Reson. 2015; 17: 73
- Cardiovascular magnetic resonance by non contrast T1-mapping allows assessment of severity of injury in acute myocardial infarction.J Cardiovasc Magn Reson. 2012; 14: 15
- Cardiac magnetic resonance demonstrates myocardial oedema in remote tissue early after reperfused myocardial infarction.Arch Cardiovasc Dis. 2009; 102: 633-639
- Pathophysiology of LV remodeling in survivors of STEMI inflammation, remote myocardium, and prognosis.JACC Cardiovasc Imaging. 2015; 8: 779-789
- Acute left ventricular remodeling following myocardial infarction: coupling of regional healing with remote extracellular matrix expansion.JACC Cardiovasc Imaging. 2012; 5: 884-893
- Remote zone extracellular volume and left ventricular remodeling in survivors of ST-elevation myocardial infarction.Hypertension. 2016; 68: 385-391
- Prognostic significance of infarct core pathology revealed by quantitative non-contrast in comparison with contrast cardiac magnetic resonance imaging in reperfused ST-elevation myocardial infarction survivors.Eur Heart J. 2016; 37: 1044-1059
- Assessment of intramyocardial hemorrhage by T1-weighted cardiovascular magnetic resonance in reperfused acute myocardial infarction.J Cardiovasc Magn Reson. 2012; 14: 59
- Characterizing myocardial edema and hemorrhage using quantitative T2 and T2* mapping at multiple time intervals post ST-segment elevation myocardial infarction.Circ Cardiovasc Imaging. 2012; 5: 566-572
- Detection of acute reperfusion myocardial hemorrhage with cardiac MR imaging: T2 versus T2.Radiology. 2013; 269: 387-395
- T1 mapping in ischaemic heart disease.Eur Heart J Cardiovasc Imaging. 2014; 15: 597-602
- Gadolinium-free cardiac MR stress T1-mapping to distinguish epicardial from microvascular coronary disease.J Am Coll Cardiol. 2018; 71: 957-968
- Cardiac magnetic resonance T2 mapping in the monitoring and follow-up of acute cardiac transplant rejection: a pilot study.Circ Cardiovasc Imaging. 2012; 5: 782-790
- Improved detection of cardiac sarcoidosis using magnetic resonance with myocardial T2 mapping.Am J Respir Crit Care Med. 2014; 189: 109-112
- Improved detection of myocardial involvement in acute inflammatory cardiomyopathies using T2 mapping.Circ Cardiovasc Imaging. 2012; 5: 102-110
- T1 Mapping for the diagnosis of acute myocarditis using CMR: comparison to T2-Weighted and late gadolinium enhanced imaging.JACC Cardiovasc Imaging. 2013; 6: 1048-1058
- Comprehensive cardiac magnetic resonance imaging in patients with suspected myocarditis the MyoRacer-trial.J Am Coll Cardiol. 2016; 67: 1800-1811
- Native T1-mapping detects the location, extent and patterns of acute myocarditis without the need for gadolinium contrast agents.J Cardiovasc Magn Reson. 2014; 16: 36
- Incremental value of quantitative CMR including parametric mapping for the diagnosis of acute myocarditis.Eur Heart J Cardiovasc Imaging. 2016; 17: 154-161
- Cardiovascular magnetic resonance in heart transplant patients: diagnostic value of quantitative tissue markers: T2 mapping and extracellular volume fraction, for acute rejection diagnosis.J Cardiovasc Magn Reson. 2018; 20: 59
- Multiparametric cardiovascular magnetic resonance surveillance of acute cardiac allograft rejection and characterisation of transplantation-associated myocardial injury: a pilot study.J Cardiovasc Magn Reson. 2014; 16: 52
- Persistent long-term structural, functional, and metabolic changes after stress-induced (Takotsubo) cardiomyopathy.Circulation. 2018; 137: 1039-1048
- Updates in cardiac amyloidosis: a review.J Am Heart Assoc. 2012; 1: e000364
- Cardiovascular magnetic resonance in cardiac amyloidosis.Circulation. 2005; 111: 186-193
- Native T1 mapping in transthyretin amyloidosis.JACC Cardiovasc Imaging. 2014; 7: 157-165
- Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis.JACC Cardiovasc Imaging. 2013; 6: 488-497
- Human non-contrast T1 values and correlation with histology in diffuse fibrosis.Heart. 2013; 99: 932-937
- Markedly increased volume of distribution of gadolinium in cardiac amyloidosis demonstrated by T1 mapping.J Magn Reson Imaging. 2013; 38: 1591-1595
- T1 mapping and survival in systemic light-chain amyloidosis.Eur Heart J. 2015; 36: 244-251
- Quantitative assessment of myocardial T2 relaxation times in cardiac amyloidosis.J Magn Reson Imaging. 2009; 30: 942-946
- Differential myocyte responses in patients with cardiac transthyretin amyloidosis and light-chain amyloidosis: a cardiac MR imaging study.Radiology. 2015; 277: 388-397
- Therapeutic clearance of amyloid by antibodies to serum amyloid P component.N Engl J Med. 2015; 373: 1106-1114
- Narrative review: Fabry disease.Ann Intern Med. 2007; 146: 425-433
- Cardiovascular magnetic resonance demonstration of the spectrum of morphological phenotypes and patterns of myocardial scarring in Anderson-Fabry disease.J Cardiovasc Magn Reson. 2016; 18: 14
- T1mapping with cardiovascular MRI is highly sensitive for Fabry disease independent of hypertrophy and sex.Circ Cardiovasc Imaging. 2013; 6: 637-645
- Identification and assessment of Anderson-Fabry disease by cardiovascular magnetic resonance noncontrast myocardial T1 mapping.Circ Cardiovasc Imaging. 2013; 6: 392-398
- Reproducibility of native myocardial T1 mapping in the assessment of Fabry disease and its role in early detection of cardiac involvement by cardiovascular magnetic resonance.J Cardiovasc Magn Reson. 2014; 16: 99
- Use of myocardial T1 mapping at 3.0 t to differentiate Anderson-Fabry disease from hypertrophic cardiomyopathy.Radiology. 2018; 288: 398-406
- Cardiac Fabry disease with late gadolinium enhancement is a chronic inflammatory cardiomyopathy.J Am Coll Cardiol. 2016; 15: 1707-1708
- Cardiac phenotype of prehypertrophic Fabry disease.Circ Cardiovasc Imaging. 2018; 11: e007168
- On T2* magnetic resonance and cardiac iron.Circulation. 2011; 123: 1519-1528
- Cardiac T2* magnetic resonance for prediction of cardiac complications in Thalassemia Major.Circulation. 2009; 120: 1961-1968
- Noncontrast myocardial T1 mapping using cardiovascular magnetic resonance for iron overload.J Magn Reson Imaging. 2015; 41: 1505-1511
- T1 at 1.5T and 3T compared with conventional T2* at 1.5T for cardiac siderosis.J Cardiovasc Magn Reson. 2015; 17: 102
- Quantification of myocardial extracellular volume fraction with cardiac MR imaging in Thalassemia major.Radiology. 2016; 279: 720-730
- Athletic cardiac adaptation in males is a consequence of elevated myocyte mass.Circ Cardiovasc Imaging. 2016; 9: e003579
- Native T1 and T2 mapping by CMR in lupus myocarditis: disease recognition and response to treatment.Int J Cardiol. 2016; 222: 717-726
- Advanced myocardial tissue characterisation by a multi-component CMR protocol in patients with rheumatoid arthritis.Eur Radiol. 2017; 27: 4639-4649
- Diffuse myocardial fibrosis and inflammation in rheumatoid arthritis: insights from CMR T1 Mapping.JACC Cardiovasc Imaging. 2015; 8: 526-536
- The relationship between cardiovascular magnetic resonance imaging measurement of extracellular volume fraction and clinical outcomes in adults with repaired tetralogy of Fallot.Eur Heart J Cardiovasc Imaging. 2018; 19: 777-784
- Diffuse myocardial fibrosis following tetralogy of Fallot repair: a T1 mapping cardiac magnetic resonance study.Pediatr Radiol. 2014; 44: 403-409
- Extracellular volume fraction mapping in the myocardium, part 2: initial clinical experience.J Cardiovasc Magn Reson. 2012; 14: 64
- Evaluation of age-related interstitial myocardial fibrosis with cardiac magnetic resonance contrast-enhanced T1mapping: MESA (Multi-Ethnic Study of Atherosclerosis).J Am Coll Cardiol. 2013; 62: 1280-1287
- Normal variation of magnetic resonance T1 relaxation times in the human population at 1.5 T using ShMOLLI.J Cardiovasc Magn Reson. 2013; 15: 13
- Saturation recovery single-shot acquisition (SASHA) for myocardial T 1 mapping.Magn Reson Med. 2014; 71: 2082-2095
- Normal diastolic and systolic myocardial T1 values at 1.5-T MR imaging: correlations and blood normalization.Radiology. 2014; 271: 365-372
- Reference values for healthy human myocardium using a T1 mapping methodology: results from the International T1 Multicenter cardiovascular magnetic resonance study.J Cardiovasc Magn Reson. 2014; 16: 69
- Myocardial T2 mapping with respiratory navigator and automatic nonrigid motion correction.Magn Reson Med. 2012; 68: 1570-1578
- A single breath-hold multiecho T2* cardiovascular magnetic resonance technique for diagnosis of myocardial iron overload.J Magn Reson Imaging. 2003; 18: 33-39
- Multislice multiecho T2* cardiovascular magnetic resonance for detection of the heterogeneous distribution of myocardial iron overload.J Magn Reson Imaging. 2006; 23: 662-668
- Myocardial T2* is not affected by ageing, myocardial fibrosis, or impaired left ventricular function.J Magn Reson Imaging. 2010; 32: 1095-1098
Article info
Footnotes
Disclosures: None.
Identification
Copyright
© 2019 Elsevier Inc. All rights reserved.
